A detailed history of Pnc Financial Services Group, Inc. transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 5,572 shares of ROIV stock, worth $70,708. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,572
Previous 5,699 2.23%
Holding current value
$70,708
Previous $60,000 6.67%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$10.17 - $12.5 $1,291 - $1,587
-127 Reduced 2.23%
5,572 $64,000
Q2 2024

Aug 09, 2024

BUY
$10.36 - $11.74 $46,143 - $52,289
4,454 Added 357.75%
5,699 $60,000
Q1 2024

May 10, 2024

BUY
$9.87 - $11.8 $6,395 - $7,646
648 Added 108.54%
1,245 $13,000
Q4 2023

Feb 09, 2024

BUY
$8.38 - $11.58 $2,614 - $3,612
312 Added 109.47%
597 $6,000
Q3 2023

Nov 13, 2023

BUY
$9.76 - $13.19 $2,781 - $3,759
285 New
285 $3,000

Others Institutions Holding ROIV

About Roivant Sciences Ltd.


  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $8.94B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.